NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available
here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package
read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read
here
See how UMR members are aiding in the fight against the coronavirus
here
A new episode of the
Amazing Things Podcast is now available! Check it out
here.
Moderna edges out Pfizer vaccine in head-to-head comparison
Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including documented SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalization, intensive care unit admission, and death, over a 24-week period, according to a team of researchers. This pattern was consistent for periods when Alpha or Delta were the predominant variant.
